ID: ALA1161801

Max Phase: Preclinical

Molecular Formula: C13H13O4P

Molecular Weight: 264.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=P(O)(O)C(O)(c1ccccc1)c1ccccc1

Standard InChI:  InChI=1S/C13H13O4P/c14-13(18(15,16)17,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10,14H,(H2,15,16,17)

Standard InChI Key:  LWFBFIRSIKNULR-UHFFFAOYSA-N

Associated Targets(non-human)

Mandelate racemase 27 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 264.22Molecular Weight (Monoisotopic): 264.0551AlogP: 2.06#Rotatable Bonds: 3
Polar Surface Area: 77.76Molecular Species: ACIDHBA: 2HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.08CX Basic pKa: CX LogP: 2.39CX LogD: -0.10
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.74Np Likeness Score: 0.09

References

1. Burley RK, Bearne SL..  (2005)  Inhibition of mandelate racemase by the substrate-intermediate-product analogue 1,1-diphenyl-1-hydroxymethylphosphonate.,  15  (19): [PMID:16039120] [10.1016/j.bmcl.2005.06.060]

Source